FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome

Press/Media

Period	19 Oct 2023

Media coverage

Title	FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome
Media name/outlet	NS Medical Devices
Country/Territory	United Kingdom
Date	19/10/23
URL	https://www.nsmedicaldevices.com/news/fda-grants-seastar-medicals-selective-cytopheretic-device-breakthrough-device-designation-for-hepatorenal-syndrome/
Persons	Kevin Chung